Mode of Selection and Experimental Evolution of Antifungal Drug Resistance in Saccharomyces cerevisiae

Corresponding author: James B. Anderson, University of Toronto, 3359 Mississauga Rd., North Mississauga, ON L5L 1C6, Canada., janderso{at}utm.utoronto.ca (E-mail)

Communicating editor: A. P. MITCHELL

We show that mode of selection, degree of dominance of mutations, and ploidy are determining factors in the evolution of resistance to the antifungal drug fluconazole in yeast. In experiment 1, yeast populations were subjected to a stepwise increase in fluconazole concentration over 400 generations. Under this regimen, two mutations in the same two chromosomal regions rose to high frequency in parallel in three replicate populations. These mutations were semidominant and additive in their effect on resistance. The first of these mutations mapped to PDR1 and resulted in the overexpression of the ABC transporter genes PDR5 and SNQ2. These mutations had an unexpected pleiotropic effect of reducing the residual ability of the wild type to reproduce at the highest concentrations of fluconazole. In experiment 2, yeast populations were subjected to a single high concentration of fluconazole. Under this regimen, a single recessive mutation appeared in each of three replicate populations. In a genome-wide screen of 4700 viable deletion strains, 13 were classified as resistant to fluconazole (ERG3, ERG6, YMR102C, YMR099C, YPL056C, ERG28, OSH1, SCS2, CKA2, SML1, YBR147W, YGR283C, and YLR407W). The mutations in experiment 2 all mapped to ERG3 and resulted in the overexpression of the gene encoding the drug target ERG11, but not PDR5 and SNQ2. Diploid hybrids from experiments 1 and 2 were less fit than the parents in the presence of fluconazole. In a variation of experiment 2, haploids showed a higher frequency of resistance than diploids, suggesting that degree of dominance and ploidy are important factors in the evolution of antifungal drug resistance.

This article has been cited by other articles:

				J. B. Anderson, C. Sirjusingh, N. Syed, and S. Lafayette Gene Expression and Evolution of Antifungal Drug Resistance Antimicrob. Agents Chemother., May 1, 2009; 53(5): 1931 - 1936. [Abstract] [Full Text] [PDF]

				S. P. Otto, M. R. Servedio, and S. L. Nuismer Frequency-Dependent Selection and the Evolution of Assortative Mating Genetics, August 1, 2008; 179(4): 2091 - 2112. [Abstract] [Full Text] [PDF]

				C. Schuller, Y. M. Mamnun, H. Wolfger, N. Rockwell, J. Thorner, and K. Kuchler Membrane-active Compounds Activate the Transcription Factors Pdr1 and Pdr3 Connecting Pleiotropic Drug Resistance and Membrane Lipid Homeostasis in Saccharomyces cerevisiae Mol. Biol. Cell, December 1, 2007; 18(12): 4932 - 4944. [Abstract] [Full Text] [PDF]

				S. Collins, J. de Meaux, and C. Acquisti Adaptive Walks Toward a Moving Optimum Genetics, June 1, 2007; 176(2): 1089 - 1099. [Abstract] [Full Text] [PDF]

				P. J. Riggle and C. A. Kumamoto Transcriptional Regulation of MDR1, Encoding a Drug Efflux Determinant, in Fluconazole-Resistant Candida albicans Strains through an Mcm1p Binding Site Eukaryot. Cell, December 1, 2006; 5(12): 1957 - 1968. [Abstract] [Full Text] [PDF]

				J. B. Anderson, N. Ricker, and C. Sirjusingh Antagonism between Two Mechanisms of Antifungal Drug Resistance. Eukaryot. Cell, August 1, 2006; 5(8): 1243 - 1251. [Abstract] [Full Text] [PDF]

				A. Selmecki, A. Forche, and J. Berman Aneuploidy and Isochromosome Formation in Drug-Resistant Candida albicans. Science, July 21, 2006; 313(5785): 367 - 370. [Abstract] [Full Text] [PDF]

				A. Coste, V. Turner, F. Ischer, J. Morschhauser, A. Forche, A. Selmecki, J. Berman, J. Bille, and D. Sanglard A Mutation in Tac1p, a Transcription Factor Regulating CDR1 and CDR2, Is Coupled With Loss of Heterozygosity at Chromosome 5 to Mediate Antifungal Resistance in Candida albicans Genetics, April 1, 2006; 172(4): 2139 - 2156. [Abstract] [Full Text] [PDF]

				L. E. Cowen and S. Lindquist Hsp90 Potentiates the Rapid Evolution of New Traits: Drug Resistance in Diverse Fungi Science, September 30, 2005; 309(5744): 2185 - 2189. [Abstract] [Full Text] [PDF]

				J. B. Anderson, C. Sirjusingh, and N. Ricker Haploidy, Diploidy and Evolution of Antifungal Drug Resistance in Saccharomyces cerevisiae Genetics, December 1, 2004; 168(4): 1915 - 1923. [Abstract] [Full Text] [PDF]

				S. Markovich, A. Yekutiel, I. Shalit, Y. Shadkchan, and N. Osherov Genomic Approach to Identification of Mutations Affecting Caspofungin Susceptibility in Saccharomyces cerevisiae Antimicrob. Agents Chemother., October 1, 2004; 48(10): 3871 - 3876. [Abstract] [Full Text] [PDF]